26Aug 2023
Long‐acting glucagon‐like peptide 1 receptor agonists boost erectile function in men with type 2 diabetes mellitus complaining of erectile dysfunction

Long‐acting glucagon‐like peptide 1 receptor agonists boost erectile function in men with type 2 diabetes mellitus complaining of erectile dysfunction

Discover how GLP-1 receptor agonists (GLP-1RAs) and metformin impact erectile dysfunction in type 2 diabetes. This retrospective study found improved glucose management, weight loss, and increased testosterone levels with GLP-1RAs plus metformin treatment. While promising, randomized clinical trials are needed for conclusive evidence of their effectiveness.

  • #urology

Like

Save

Share